Titan previously announced on June 11, 2020, the completion of a non-technical financial milestone pursuant to the development agreement, with the satisfactory raising of U.S
The increase in patient weight and improvement in appetite can give them more energy to cope with disease treatment and rehabilitation, reducing the occurrence of complications caused by physical weakness
MRAB biofilms were treated with 4 g/mL, 12 g/mL, MBC (1516 g/mL) and 20 g/mL amikacin, 10 and 20 g/mL ciprofloxacin, 10 and 20 g/mL Augmentin and 10 and 20 g/mL tobramycin individually, or in combination with GSH
Changes in glutathione levels have been implicated in a range of diseases and conditions, including cancer, liver diseases, and neurodegenerative disorders